Company type | Public |
---|---|
Industry | Healthcare |
Founded | 2005 |
Headquarters | Boston, United States |
Key people | Christopher Viehbacher (Chairman) Daphne Zohar (CEO) |
Products | Medicines |
Revenue | $3.3 million (2023)[1] |
$(146.2) million (2023)[1] | |
$(66.6) million (2023)[1] | |
Website | puretechhealth |
PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.